6,7-Dihydro-5h-pyrazolo[1,2-a]pyrazol-1 -ones which control inflammatory cytokines

Details for Australian Patent Application No. 2002327690 (hide)

Owner The Procter & Gamble Company

Inventors De, Biswanath; Djung, Jane Far-Jine; Natchus, Michael George; Laufersweiler, Matthew John; Clark, Michael Phillip

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002327690

PCT Number PCT/US02/30135

PCT Pub. Number WO2003/024971

Priority 60/323,625 20.09.01 US

Filing date 20 September 2002

Wipo publication date 1 April 2003

Acceptance publication date 20 July 2006

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

23 January 2003 Complete Application Filed

  Priority application(s): 60/323,625 20.09.01 US

5 June 2003 Application Open to Public Inspection

  Published as AU-B-2002327690

20 July 2006 Application Accepted

  Published as AU-B-2002327690

23 November 2006 Standard Patent Sealed

14 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002327691-LOAD BALANCED SCALABLE NETWORK GATEWAY PROCESSOR ARCHITECTURE

2002327689-Compounds which inhibit the release of inflammatory cytokines